| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.0009 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |